← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 20, 2018Last known activity
Jul 18, 2025
Timeline
2010s
- Jun 1, 2012
Emtora Biosciences— Founded
Drugs by trial phase (1 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT06950385Lead sponsorPhase 3Jul 18, 2025
- NCT04375813Lead sponsorPhase 2Jul 31, 2020
- NCT04230499Lead sponsorPhase 2Feb 29, 2020
- NCT03618355Lead sponsorPhase 1Jul 20, 2018
Details
- Founded
- San Antonio, TX, US Jun 1, 2012
- Last known activity
- Jul 18, 2025
Notes
formerly Rapamycin Holdings Inc.